May 29, 2026 Researchers are working to improve treatment for myelofibrosis By Katz CommunicationsResearchers at the Lewis Katz School of Medicine and Fox Chase Cancer Center are advancing a […] Mar. 26, 2026 New Vulnerability in Aggressive Leukemia Discovered by Researchers By Katz CommunicationsA potential weakness in a common form of leukemia could lead to new treatments. The […] Aug. 28, 2025 Common Intracellular Toxin Could Help Fight Leukemia By Katz Communication All cells naturally produce formaldehyde as a byproduct of metabolism. To survive this toxic […] Dec. 18, 2024 Pete Vulfson’s Journey to Katz: Embracing Opportunity and Knowledge By Katz CommunicationsAs a first-year PhD student at the Lewis Katz School of Medicine, Pete Vulfson is excited to share […] Oct. 7, 2024 Researchers From Fels Cancer Institute for Personalized Medicine and Fox Chase Cancer Center Reveal Surprising Mechanism for Activating DNA Repair in Cancer By Katz CommunicationsAn enzyme called DNA polymerase theta plays a key role in repairing DNA damage to cancer cells, […] Mar. 22, 2024 Star Wars Against Cancer: Attacking the Clones — Novel Strategy Could Mean More Durable Treatment for Leukemia By Katz CommunicationsScientists at the Fels Cancer Institute for Personalized Medicine and the Department of Cancer and […] Aug. 13, 2021 Fels and Fox Chase Researchers Highlight Roles of TET2 and DNMT3A Mutations in Personalized Medicine-Guided Synthetic Lethality Against Leukemia By Katz CommunicationsIn a recent study published in Cancer Research, researchers from Fels Cancer Institute for […]
May 29, 2026 Researchers are working to improve treatment for myelofibrosis By Katz CommunicationsResearchers at the Lewis Katz School of Medicine and Fox Chase Cancer Center are advancing a […] Mar. 26, 2026 New Vulnerability in Aggressive Leukemia Discovered by Researchers By Katz CommunicationsA potential weakness in a common form of leukemia could lead to new treatments. The […] Aug. 28, 2025 Common Intracellular Toxin Could Help Fight Leukemia By Katz Communication All cells naturally produce formaldehyde as a byproduct of metabolism. To survive this toxic […] Dec. 18, 2024 Pete Vulfson’s Journey to Katz: Embracing Opportunity and Knowledge By Katz CommunicationsAs a first-year PhD student at the Lewis Katz School of Medicine, Pete Vulfson is excited to share […] Oct. 7, 2024 Researchers From Fels Cancer Institute for Personalized Medicine and Fox Chase Cancer Center Reveal Surprising Mechanism for Activating DNA Repair in Cancer By Katz CommunicationsAn enzyme called DNA polymerase theta plays a key role in repairing DNA damage to cancer cells, […] Mar. 22, 2024 Star Wars Against Cancer: Attacking the Clones — Novel Strategy Could Mean More Durable Treatment for Leukemia By Katz CommunicationsScientists at the Fels Cancer Institute for Personalized Medicine and the Department of Cancer and […] Aug. 13, 2021 Fels and Fox Chase Researchers Highlight Roles of TET2 and DNMT3A Mutations in Personalized Medicine-Guided Synthetic Lethality Against Leukemia By Katz CommunicationsIn a recent study published in Cancer Research, researchers from Fels Cancer Institute for […]
